BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Theilacker C, Fletcher MA, Jodar L, Gessner BD. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022;10:127. [PMID: 35056576 DOI: 10.3390/microorganisms10010127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mugwagwa T, Averin A, Atwood M, Sato R, Vyse A, Campling J, Weycker D, Slack M, Ellsbury G, Mendes D. Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England. Expert Rev Vaccines 2022. [PMID: 35929956 DOI: 10.1080/14760584.2022.2104250] [Reference Citation Analysis]
2 Theilacker C, Fletcher MA, Jodar L, Gessner BD. Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022, 10, 127. Microorganisms 2022;10:1018. [DOI: 10.3390/microorganisms10051018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Leblanc JJ, Elsherif M, Ye L, Mackinnon-cameron D, Ambrose A, Hatchette TF, Lang AL, Gillis HD, Martin I, Demczuk WH, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, Mccarthy AE, Mcgeer A, Semret M, Trottier S, Valiquette L, Webster D, Mcneil SA. Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.081] [Reference Citation Analysis]
4 Vyse A, Campling J, Czudek C, Ellsbury G, Mendes D, Reinert RR, Slack MPE. Response to Dawson et al: Letter to the Editor on "A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK". Expert Rev Vaccines 2022. [PMID: 35226814 DOI: 10.1080/14760584.2022.2047024] [Reference Citation Analysis]